Can Lyme Disease Affect Pregnancy?
Yes, Lyme disease can affect pregnancy, but when appropriately treated with antibiotics, outcomes are generally favorable and there is little evidence of a specific congenital Lyme disease syndrome. 1
Key Evidence on Pregnancy Outcomes
The most important finding from the evidence is that untreated Lyme disease during pregnancy carries significantly higher risk of adverse outcomes compared to treated disease. A 22-year study of 95 pregnant women with Lyme disease found that untreated women had a 60% rate of adverse outcomes versus 12.1% in those treated parenterally (odds ratio 7.61, p=0.004) 2. However, large prospective studies consistently show that when pregnant women receive appropriate antibiotic therapy, there is no increased risk of fetal death, prematurity, or congenital malformations 3, 4.
Treatment Approach During Pregnancy
Pregnant women should be treated identically to non-pregnant patients with the same disease manifestation, with the critical exception that doxycycline must be avoided 1.
First-Line Treatment Options:
- Amoxicillin 500 mg three times daily for 14 days (early localized disease)
- Cefuroxime axetil 500 mg twice daily for 14 days (early localized disease)
- Ceftriaxone 2 g IV once daily for 14 days for neurologic involvement or severe disease 1
The guideline explicitly states that doxycycline is relatively contraindicated in pregnant or lactating women 1. This is the only modification needed for pregnancy—all other treatment regimens remain the same.
Clinical Presentation in Pregnancy
Interestingly, pregnant women with erythema migrans report constitutional symptoms less frequently than non-pregnant women (22.4% vs 37.2%, p<0.001), and symptoms become even milder as pregnancy progresses 5. Among reported Lyme disease cases, pregnant women more commonly present with early manifestations (66% with only erythema migrans rash) compared to non-pregnant females (60%) 6. This pattern suggests either earlier detection due to frequent prenatal care contact or increased self-advocacy during pregnancy.
Adverse Outcomes: What the Data Shows
While case reports have suggested possible associations between gestational Lyme disease and adverse outcomes, no specific pattern of teratogenicity has been demonstrated, and a causal relationship has never been proven 4. The most common adverse outcomes reported include:
- Preterm birth (most frequent)
- Fetal/perinatal death (rare)
- Various heterogeneous complications 2
However, many cases with adverse outcomes had alternative explanations unrelated to Lyme disease 2, 5.
Critical Pitfalls to Avoid
- Do not withhold treatment: The risk of untreated disease far exceeds any theoretical risk from appropriate antibiotics during pregnancy
- Do not use doxycycline: This is the only absolute contraindication in pregnancy
- Do not assume congenital syndrome exists: Despite concerns based on other spirochetal diseases (like syphilis), there is no evidence of a specific congenital Lyme disease syndrome 1, 4
- Do not over-investigate: Large epidemiological studies of approximately 2,000 prenatal patients found no association between maternal Lyme disease exposure and adverse outcomes when treated 3
Treatment Efficacy and Reassurance
A study of 304 pregnant women with erythema migrans treated with IV ceftriaxone 2g daily for 14 days showed favorable pregnancy outcomes in 86.2% of cases 5. The IDSA guidelines emphasize that "a large body of data from clinical and epidemiologic studies suggest that favorable outcomes can be expected when pregnant women with Lyme disease are treated with standard antibiotic regimens" 1.
Bottom Line for Clinical Practice
When Lyme disease is diagnosed during pregnancy, treat promptly with amoxicillin, cefuroxime, or ceftriaxone (depending on disease severity), avoid doxycycline, and reassure the patient that with appropriate treatment, pregnancy outcomes are expected to be favorable. The key is early recognition and treatment—not avoiding therapy out of concern for the pregnancy.